Fusarium solani infection as an initial manifestation of AML transformation in myelodysplastic syndrome: A case report

J Mycol Med. 2018 Jun;28(2):390-392. doi: 10.1016/j.mycmed.2018.04.003. Epub 2018 May 1.
[Article in French]

Abstract

Severely immunocompromised patients are at increased risk for uncommon infectious diseases with atypical presentations. Fusarium sp., has been reported in patients with hematological malignancies and prompt diagnosis is necessary due to high mortality. We report a myelodysplastic syndrome (MDS) patient who presented Fusarium solani infection associated with granulocytic sarcoma as an initial presentation of acute myeloid leukemia (AML) transformation. We performed histological examination, immunohistochemistry analysis, culture of the biopsy tissue and DNA sequencing to make a conclusive diagnosis of F. solani and granulocytic sarcoma, reinforcing the necessity of performing complete evaluation of skin lesions in immunocompromised patients.

Keywords: Acute myeloid leukemia; Fusarium solani; Granulocytic sarcoma; Myelodysplastic syndrome.

Publication types

  • Case Reports

MeSH terms

  • Azacitidine / therapeutic use
  • Biopsy
  • Diagnosis, Differential
  • Female
  • Fusariosis / diagnosis*
  • Fusarium / drug effects
  • Fusarium / genetics
  • Fusarium / isolation & purification*
  • Humans
  • Immunocompromised Host
  • Leukemia, Myeloid, Acute / complications
  • Middle Aged
  • Mycelium / ultrastructure
  • Myelodysplastic Syndromes / microbiology*
  • Sarcoma, Myeloid / diagnosis
  • Sarcoma, Myeloid / microbiology
  • Sarcoma, Myeloid / radiotherapy
  • Sequence Analysis, DNA
  • Skin / microbiology
  • Skin / pathology

Substances

  • Azacitidine